负面情绪调节的自主指数预测了阿片类药物治疗慢性腰痛患者的治疗反应
相关实验视频
Updated: Feb 15, 2026

10:37
Development of Recombinant Proteins to Treat Chronic Pain
Published on: April 11, 2018
10.0K
Anna Parisi1, Miranda Johnson2, Aleksandra Zgierska3
1Department of Social Work, George Mason University, Fairfax, VA.
The journal of pain
|February 13, 2026
概括
认知重新评估的困难,通过心率变化来衡量,预测慢性腰部疼痛的结果会更差. 增强情绪调节可能会改善长期阿片类药物治疗患者的治疗反应.
科学领域:
- 神经科学是一个神经科学.
- 心理学 心理学 心理学
- 疼痛管理 疼痛管理
背景情况:
- 情绪调节困难与长期阿片类药物治疗 (LTOT) 患者的慢性腰痛 (CLBP) 结果更差有关.
- 高频心率变化 (HF-HRV) 可以作为情绪调节能力的生理标记.
研究的目的:
- 研究由HF-HRV索引的情绪调节能力对阿片类药物治疗的CLBP成年人心理治疗结果的影响.
- 确定情绪调节任务期间的基线HF-HRV是否预测基于正念治疗 (MBT) 或认知行为治疗 (CBT) 后的疼痛严重程度和功能干扰.
主要方法:
- 68名阿片类药物治疗的CLBP成年人接受了测量HF-HRV的情绪调节任务,并完成了疼痛评估.
- 参与者被随机分配到8周的MBT或CBT,并随时跟踪12个月,重复评估疼痛.
- 线性混合效应模型分析了基线HF-HRV与随后的疼痛严重程度和干扰之间的关系.
主要成果:
- 在认知重新评估期间,较低的基线HF-HRV预测了明显更高的疼痛严重程度和功能干扰.
- 这种关联在MBT和CBT组的12个月随访期间持续存在.
- 在情绪调节期间,自主反应的减弱表明治疗结果较差.
结论:
- 在认知重新评估期间调节自主反应的能力受损与CLBP患者的持续疼痛和功能限制有关.
- 由HF-HRV反映的认知重新评估能力可能是改善疼痛管理结果的关键治疗目标.
- 旨在增强情绪调节策略的干预措施可以改善慢性疼痛患者的自主功能和与疼痛相关的结果.
相关概念视频
Negative Regulator Molecules
38.6K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.6K
Indicators
61.2K
Certain organic substances change color in dilute solution when the hydronium ion concentration reaches a particular value. For example, phenolphthalein is a colorless substance in any aqueous solution with a hydronium ion concentration greater than 5.0 × 10−9 M (pH < 8.3). In more basic solutions where the hydronium ion concentration is less than 5.0 × 10−9 M (pH > 8.3), it is red or pink. Substances such as phenolphthalein, which can be used to determine the pH of a solution, are...
61.2K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
1.2K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.2K
Regulation of the Unfolded Protein Response
3.1K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.1K
Opioid Receptors: Overview
4.8K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
4.8K
Autonomic Nervous System
13.1K
The autonomic nervous system (ANS) is a critical component of the peripheral nervous system, primarily responsible for regulating involuntary bodily functions and maintaining homeostasis. It functions in tandem with the central nervous system (CNS) to seamlessly coordinate various physiological processes without the need for conscious control.
The ANS comprises two main divisions: the sympathetic and parasympathetic divisions. These divisions function antagonistically to maintain a dynamic...
The ANS comprises two main divisions: the sympathetic and parasympathetic divisions. These divisions function antagonistically to maintain a dynamic...
13.1K

